ASweetLife Team, Author at ASweetLife

Lilly to Open Diabetes Research Center in Shanghai, China

Eli Lilly has announced plans to open a diabetes research center in Shanghai, China. The center, planned to open in the second half of 2011, will focus on discovering new medicines to treat diabetes. According to a recent article in The New England Journal of Medicine, an estimated 92 million people in China - almost 10 percent of the adult population - have diabetes...

FDA Issues Complete Response Letter to Biodel New Diabetes Drug Application

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) requesting additional information regarding Biodel Inc.'s new drug application (NDA) for Linjeta a more-rapid-acting human insulin injection for the treatment of type 1 and type 2 diabetes. The CRL stated that the FDA's review cycle is complete and that the application cannot be...

National Diabetes Awareness Month and World Diabetes Day

November is Diabetes Awareness Month and November 14th is World Diabetes Day, and there are many efforts, campaigns, and initiatives taking place. The American Diabetes Association has launched a video contest which runs throughout the month. Click here to find out how you can share your vision to stop diabetes. JDRF is running a campaign called Type 1 Talk, with a video introduction by Crystal Bowersox.

The Very Best Recipes For Health: 250 Recipes (and More) From Martha Rose Shulman

Martha Rose Shulman's new cookbook, a compilation of recipes from her popular NYTimes.com feature, offers readers health-conscious and delicious dishes. While this isn't meant to be a diabetes cookbook (you'll find some grain-based and pasta recipes) there are still plenty of excellent choices for us within its pages. Shulman has chapters devoted to salads, simple vegetables, and fish and poultry dishes.

Vitamin D Deficiency Linked to Risk of Death From Cardiovascular Disease in People with Diabetes

According to a study published in the October issue of Diabetes Care, patients with type 2 diabetes who have a vitamin D deficiency have an increased risk of death from cardiovascular disease....

Novartis Receives Positive Opinion on New Diabetic Macular Edema Drug

Novartis has announced that it has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for Lucentis (ranibizumab) for the treatment of patients with visual impairment due to diabetic macular edema (DME). The submission was supported by data from two Novartis-funded clinical trials, RESTORE and RESOLVE, which showed that Lucentis...

Eli Lilly Suspends Trials for New Type 1 Diabetes Drug

Eli Lilly and Co. and MacroGenics Inc. announced that the Protege Data Monitoring Committee (DMC), has completed a planned analysis of one-year safety and efficacy data of the Protege Phase 3 clinical trial of teplizumab. The DMC, composed of independent experts in the fields of diabetes and biostatistics, concluded that the primary efficacy endpoint of the study was not met...

FDA Requests Further Testing On Amylin’s New Type 2 Diabetes Drug

In the complete response letter regarding the New Drug Application (NDA) for Bydureon (exenatide extended-release for injectable suspension) issued Tuesday the FDA requested Amylin Pharmaceuticals, Eli Lilly and Alkermesa conduct a thorough QT study which would look at the new drug's effect on patients' heart rates...

FDA Requests Further Testing On Amylin’s New Type 2 Diabetes Drug

In the complete response letter regarding the New Drug Application (NDA) for Bydureon (exenatide extended-release for injectable suspension) issued Tuesday the FDA requested Amylin Pharmaceuticals, Eli Lilly and Alkermesa conduct a thorough QT study which would look at the new drug's effect on patients' heart rates...

D. Medical Insulin Pump to be Distributed in Greece

D. Medical Industries Ltd. announced the execution of a distribution agreement with Pharmaserve-Lilly S.A.C.I. ("Pharmaserve-Lilly") for the distribution of its ADI durable insulin pump, related consumables and its Universal Detach Detect Infusion Sets in Greece. The ADI pump, developed by D. Medical subsidiary Spring, is the only insulin pump on the market today that implements a spring-based...